Ganglioside GM3 Levels Are Altered in a Mouse Model of HIBM: GM3 as a Cellular Marker of the Disease

Thomas Paccalet, Zoé Coulombe, Jacques P. Tremblay · 2010

Read Ganglioside GM3 Levels Are Altered in a Mouse Model of HIBM: GM3 as a Cellular Marker of the Disease by Thomas Paccalet, Zoé Coulombe, Jacques P. Tremblay (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010055.txt.

Description

Thomas Paccalet, Zoe Coulombe, and Jacques Tremblay report a 2010 PLOS ONE mouse study on a rare inherited muscle disease, HIBM. It causes slow adult-onset weakness while sparing the thigh muscle at first. A faulty GNE gene, needed to make a cell sugar acid, causes it.

The team tested whether a muscle fat called GM3 also goes wrong. In mice with the human gene fault, muscle GM3 levels dropped sharply, and so did the message for its making enzyme. Kidney levels stayed normal, so the change is tissue specific. For the first time, a GNE fault is tied to a clear cell change, marking GM3 as a disease sign.

Catalog record

CREATORThomas Paccalet, Zoé Coulombe, Jacques P. Tremblay
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE39 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010055

Browse the full library · About the Tower of Babel